In the ever-changing and fiercely competitive business landscape, conducting thorough company analysis is crucial for investors and industry experts. In this article, we will undertake a comprehensive industry comparison, evaluating Merck & Co (NYSE:MRK) and its primary competitors in the Pharmaceuticals industry. By closely examining key financial metrics, market position, and growth prospects, our aim is to provide valuable insights for investors and shed light on company's performance within the industry.
Merck & Co Background
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
Company | P/E | P/B | P/S | ROE | EBITDA (in billions) | Gross Profit (in billions) | Revenue Growth |
---|---|---|---|---|---|---|---|
Merck & Co Inc | 914.21 | 8.63 | 5.42 | -3.11% | $-0.77 | $10.72 | 5.78% |
Eli Lilly and Co | 135.21 | 69.22 | 20.76 | 19.91% | $3.03 | $7.57 | 28.1% |
Novo Nordisk A/S | 46.52 | 36.27 | 16.76 | 22.01% | $28.51 | $55.85 | 36.95% |
Johnson & Johnson | 29.31 | 5.34 | 4.58 | 5.78% | $6.82 | $14.6 | 7.3% |
AstraZeneca PLC | 35.41 | 5.34 | 4.60 | 2.52% | $2.18 | $9.72 | 7.29% |
Novartis AG | 23.36 | 4.20 | 4.29 | 19.99% | $4.18 | $8.75 | 7.39% |
Pfizer Inc | 72.05 | 1.70 | 2.57 | -3.62% | $-1.77 | $6.69 | -41.34% |
Sanofi SA | 20.29 | 1.47 | 2.36 | -0.75% | $0.42 | $8.15 | 6.5% |
Bristol-Myers Squibb Co | 13.30 | 3.53 | 2.37 | 6.03% | $4.45 | $8.73 | 0.62% |
GSK PLC | 13.58 | 4.98 | 2.21 | 2.64% | $1.16 | $5.63 | 9.16% |
Zoetis Inc | 32.71 | 15.20 | 8.97 | 10.42% | $0.83 | $1.49 | 8.48% |
Takeda Pharmaceutical Co Ltd | 36.72 | 0.96 | 1.56 | 1.53% | $314.89 | $731.71 | 1.33% |
Viatris Inc | 236 | 0.68 | 0.92 | -3.7% | $-0.07 | $1.6 | -1.0% |
Dr Reddy's Laboratories Ltd | 19.63 | 3.82 | 3.78 | 5.29% | $22.42 | $42.2 | 6.57% |
Jazz Pharmaceuticals PLC | 19.10 | 1.94 | 2.19 | 2.61% | $0.29 | $0.9 | 4.1% |
Corcept Therapeutics Inc | 26.82 | 5.15 | 5.84 | 6.43% | $0.03 | $0.13 | 31.39% |
Average | 50.67 | 10.65 | 5.58 | 6.47% | $25.82 | $60.25 | 7.52% |